News Judge throws out Allergan patents, criticises Native America... Federal court throws out patents on Restasis
News Copaxone first on FDA's list for faster complex generic appr... Teva will attempt to block generic launch in courts
News Huntington's Disease wearable gets backing from NIH BioSensics' HDWear provides real-time motor function scores in Huntington's patients.
News Teva sells women's health division to tackle $35bn debts Teva has sold its women’s health business in order to pay off some of its $35 billion in debts built up in acquiring Allergan’s generics business.
News Teva appoints Lundbeck's Kare Schultz as CEO Unlike AZ's Soriot, Schultz "couldn't refuse" top job at Teva.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
